Background: The recognition of phosphorylated non-
Introduction
Tuberculosis in children is usually due to a primary infection (1) . Anti-Mycobacterium tuberculosis (MTB) immunity depends on the interaction of antigen-major histocompatibility (MJHC) class I molecules (12) (13) (14) (15) (16) (17) . These inhibitory receptors may control their reactivities toward conserved self-antigens and exogenous mycobacterial ligands (12) . The phosphoantigenic recognition requires neither antigen uptake/processing nor classical polymorphic or nonpolymorphic MHC molecules, allowing for a rapid response to microbial immune challenge (18) . This recognition is severely impaired in some patients with chronic viral (19, 20) or bacterial (21) infections. Here we report our analyses of -y8 T cell reactivities to phosphoantigens ex vivo in primary MTB-infected children and in vivo in rhesus monkeys (Macaca mulatta).
Materials and Methods

Cell Preparation and Stimulation
Peripheral blood mononuclear cells (PBMC) were isolated from 22 children with MTB infections (13 males, 9 females; 5.2 ± 3.3 years of age, range [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] years). Fourteen patients suffered from pulmonary MTB, four had MTB meningitis, three had lymphatic MTB, and one had renal MTB. The diagnoses of MTB infections were established by the presence of clinical symptoms, by the positivity of tuberculin (PPD) skin test, and by chest radiography. In some cases (i.e., MTB meningitis and renal MTB), positive cultures of microorganisms and/or MTB detection by polymerase chain reaction (PCR) further supported the clinical diagnosis. PPD-negative healthy children (9 males, 7 females; 6.2 ± 2.5 years of age, range 3-12 years) served as controls. Informed consent was obtained for each patient and control subject. In addition, PBMC were isolated from 12 healthy rhesus monkeys (5-13 years old). Mononuclear cells were cultured at 106 cells/ml in a complete culture medium [RPMI-1640, 10% v/v heat-inactivated fetal bovine serum (FBS), 2 mM L-glutamine, 100 IU/ml penicillin, and 100 jig/ml streptomycin].
Long-term cultures (10-14 days) were supplemented with 100 U/ml of recombinant interleukin-2 (IL-2) (Boehringer Mannheim, Mannheim, Germany), whereas short-term cultures (4 days) were performed in the presence of 5 U/ml of IL-2. Vy9V82 T cells were stimulated with the following: 0.5 mM ribose-l-phosphate (Rib-I-P, Sigma Table 1) . The Vy9V82 T cell subset in tuberculin-positive MTB-infected children responded well to all antigens used. The strongest responses were detected using IPP, with the mean expansion index of 61. In contrast, the IPP-induced expansion of Vy9V82 T cells from healthy, tuberculin-negative children was approximately 10 times lower, with the mean expansion index of 6. The absolute and relative numbers of y6 T cells, Vy9V62 T cells, and V82/ CD45RO cells measured in these children as well as in some additional young TB patients and controls were comparable ( Table 2 ). The y6 T cell response was further studied in 15 tuberculinpositive children 3 to 9 months after chemotherapy (23) . The increased responsiveness of Vy9VS2 cells sharply declined close to the levels detected in healthy tuberculin-negative children (Fig. 1 ). This suggests that persistent mycobacterial exposure was required for the presence of hyperactivity against phosphoantigens. In contrast, responses of afB T lymphocytes to tuberculin (PPD) and to the immunodominant 38 kDa protein of MTB (24) were increased after chemotherapy (data not shown). Months after chemotherapy 
